Straumann Holding AG
Straumann lifts first-half sales by 33% to CHF 217 million (Part 3 of 3)
Corporate-news announcement processed and sent by DGAP.
The sender is solely responsible for the contents of this announcement.
——————————————————————————–
Download the full media release, including additional financial tables:
http://www.newsbox.ch/public/1384/att/1205_mediarelease.pdf
Straumann lifts first-half sales by 33% to CHF 217 million (Part 3 of 3)
Disclaimer
This interim report contains certain “forward-looking statements”, which can be
identified by the use of terminology such as “scheduled to”, “will”, “expected
to”, “forecast”, “expectation”, or similar wording. Such forward-looking
statements reflect the current views of management and are subject to known and
unknown risks, uncertainties and other factors that may cause actual results,
performance or achievements of the Group to differ materially from those
expressed or implied. These include risks related to the success of and demand
for the Group’s products, the potential for the Group’s products to become
obsolete, the Group’s ability to defend its intellectual property, the Group’s
ability to develop and commercialize new products in a timely manner, the
dynamic and competitive environment in which the Group operates, the regulatory
environment, changes in currency exchange rates, the Group’s ability to generate
revenues and profitability, and the Group’s ability to realize its expansion
projects in Andover and Basel in a timely manner. Should one or more of these
risks or uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those described in this
report. Straumann is providing the information in this report as of this date
and does not undertake any obligation to update any forward-looking statements
contained in it as a result of new information, future events or otherwise.
Waldenburg, 12 August 2004
Contacts:
Gilbert Achermann, Chief Executive Officer
(+41) 061 965 1111
Martin Gertsch, Chief Financial Officer
(+41) 061 965 1111
Mark Hill, Corporate Communication
(+41) 061 965 1321
About Straumann
Headquartered in Waldenburg, Switzerland, Straumann is a global leader in oral
implantology and tissue regeneration. In collaboration with the International
Team for Implantology (ITI), leading clinics, research institutes and
universities, the Group researches, develops, produces and distributes implants,
instruments and tissue regeneration products for use in tooth replacement
solutions or to prevent tooth loss. Straumann also provides training and
services to the dental profession worldwide. Straumann’s implants and
instruments are manufactured in Switzerland, whilst its dental tissue
regeneration products are produced in Sweden. With affiliates in 14 countries
and distributors in 35, Straumann employs more than 1000 people worldwide. In
2003, the Group generated sales of CHF 344 million and a net income of CHF 80
million.
Straumann Holding AG, Hauptstrasse 26, 4427 Waldenburg, Switzerland
Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01
e-mail: investor.relations@straumann.com or info@straumann.com
Homepage: http://www.straumann.com
End part 3 of 3
end of message, (c)DGAP 12.08.2004
——————————————————————————–
WKN: 914326; ISIN: CH0012280076; Index:
Listed: Freiverkehr in Berlin-Bremen, Frankfurt, München und Stuttgart; SWX
Swiss Exchange
120637 Aug 04
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden